Skip to content

Should Colon or Non-colon Originated Lesions be Distinguished?

Acute Lower Gastrointestinal Dysfunction in Critical Care Patients: Should Colon or Non-colon Originated Lesions be Distinguished?

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02939508
Enrollment
158
Registered
2016-10-20
Start date
2015-07-31
Completion date
2017-08-31
Last updated
2016-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Lower Gastrointestinal Dysfunction

Keywords

Acute lower gastrointestinal dysfunction, Colon-originated lesions, Critical patient, Colonoscopic decompression, Anticholinergic drugs

Brief summary

This prospective study was designed to compare the difference of effects of conventional treatment, medicine intervention, endoscopic therapy, and surgery between colon originated and non-colon originated ALGID in critical patients, in order to alert doctors to differ the treatment of the two ALGID and provide basis for treatment.

Interventions

OTHERColon originated: Neostigmin, Colonoscopy decompression, Surgery
OTHERNon-colon originated: Neostigmin, Colonoscopy decompression

Sponsors

Chinese Medical Association
Lead SponsorNETWORK

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Patients in our ICU aged 18-75 years. 2. Patients with a confirmed diagnosis of ALGID.

Exclusion criteria

1. mechanical intestinal obstruction (including tumor, stercoral obstruction etc.) 2. gastrointestinal hemorrhage within 72 hours. 3. history of inflammatory bowel disease (ulcerative colitis or Crohn's disease) or radiation enteritis. 4. pregnancy. 5. contraindications of neostigmine administration.

Design outcomes

Primary

MeasureTime frame
28-day mortality after admission1-28 day after admission
ICU mortality, n (%)1-28 day after ICU admission

Secondary

MeasureTime frame
ICU stage, (day)1-60 day after ICU admission
Hospitalization, (day)1-60 day after admission
intra-abdominal pressure1-28 day after admission
Abdominal compartment syndrome1-28 day after admission

Countries

China

Contacts

Primary ContactChenyan Zhao, M.D
emmazcy@163.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026